Discussions

RNA services for cancer are important for interpreting the functional elements of the genome as well as for understanding the underlying mechanisms of diverse diseases, especially cancers. Microarray-based gene expression approaches have been used for high-throughput, large-scale RNA-level studies, such as to identify differentially expressed genes. However, the application of microarray technologies has been limited by their hybridization-based nature. Advances in massively parallel DNA sequencing technologies have enabled RNA-seq by sequencing cDNA.